Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease

Meier C, Eisenblätter M, Gielen S (2024)
Journal of cardiovascular development and disease 11(2): 40.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 1.13 MB
Abstract / Bemerkung
Cardiovascular magnetic resonance (CMR) has significantly revolutionized the comprehension and diagnosis of cardiac diseases, particularly through the utilization of late gadolinium enhancement (LGE) imaging for tissue characterization. LGE enables the visualization of expanded extracellular spaces in conditions such as fibrosis, fibrofatty tissue, or edema. The growing recognition of LGE's prognostic capacity underscores its importance, evident in the increasing explicit recommendations within guidelines. Notably, the contemporary characterization of cardiomyopathies relies on LGE-based scar assessment by CMR to a large extent. This review describes the pattern and prognostic value of LGE in detail for various cardiac diseases. Despite its merits, establishing LGE as a reliable risk marker encounters challenges. Limitations arise from the fact that not all diseases show LGE, and it should always be analyzed in the context of all CMR sequences and the patient's medical history. In summary, LGE stands as a robust indicator of adverse outcomes in diverse cardiovascular diseases. Its further integration into routine practice is desirable, necessitating widespread availability and application to accumulate both individual and scientific experience.
Stichworte
late gadolinium enhancement; cardiac magnetic resonance imaging; cardiomyopathy; myocardial vitality; risk stratification; review
Erscheinungsjahr
2024
Zeitschriftentitel
Journal of cardiovascular development and disease
Band
11
Ausgabe
2
Art.-Nr.
40
eISSN
2308-3425
Page URI
https://pub.uni-bielefeld.de/record/2987372

Zitieren

Meier C, Eisenblätter M, Gielen S. Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease. Journal of cardiovascular development and disease. 2024;11(2): 40.
Meier, C., Eisenblätter, M., & Gielen, S. (2024). Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease. Journal of cardiovascular development and disease, 11(2), 40. https://doi.org/10.3390/jcdd11020040
Meier, Claudia, Eisenblätter, Michel, and Gielen, Stephan. 2024. “Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease”. Journal of cardiovascular development and disease 11 (2): 40.
Meier, C., Eisenblätter, M., and Gielen, S. (2024). Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease. Journal of cardiovascular development and disease 11:40.
Meier, C., Eisenblätter, M., & Gielen, S., 2024. Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease. Journal of cardiovascular development and disease, 11(2): 40.
C. Meier, M. Eisenblätter, and S. Gielen, “Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease”, Journal of cardiovascular development and disease, vol. 11, 2024, : 40.
Meier, C., Eisenblätter, M., Gielen, S.: Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease. Journal of cardiovascular development and disease. 11, : 40 (2024).
Meier, Claudia, Eisenblätter, Michel, and Gielen, Stephan. “Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)-An Important Risk Marker for Cardiac Disease”. Journal of cardiovascular development and disease 11.2 (2024): 40.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
Access Level
OA Open Access
Zuletzt Hochgeladen
2024-03-12T12:22:52Z
MD5 Prüfsumme
2f3a7ce8e4e00dc9841e44a0894671b2


Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 38392254
PubMed | Europe PMC

Suchen in

Google Scholar